Related Experiment Videos
P-glycoprotein expression in primary breast cancer
1Beijing Institute for Cancer Research, Beijing Medical University, College of Clinical Oncology.
Summary
P-glycoprotein expression in breast cancer patients is linked to survival outcomes. Patients negative for P-glycoprotein showed better survival rates, indicating its role as an independent prognostic factor.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer prognosis is influenced by various factors.
- P-glycoprotein is a transmembrane protein implicated in multidrug resistance.
- Understanding prognostic markers is crucial for tailoring breast cancer treatment.
Purpose of the Study:
- To investigate the prognostic significance of P-glycoprotein expression in primary breast cancer.
- To determine if P-glycoprotein expression is an independent predictor of patient survival.
- To explore the potential influence of P-glycoprotein on breast cancer's biological behavior.
Main Methods:
- Retrospective analysis of 50 primary breast cancer specimens.
- Immunohistochemistry using monoclonal antibody C219 to detect P-glycoprotein expression.
- Statistical analysis including generalized Wilcoxon test and Cox's proportional hazards model.
Main Results:
- P-glycoprotein expression was detected in 46% (23/50) of the breast cancer patients.
- Patients with negative P-glycoprotein expression demonstrated significantly better overall survival (p = 0.0008).
- P-glycoprotein expression remained a statistically significant independent predictor of survival after multivariate analysis (p = 0.0007).
Conclusions:
- P-glycoprotein expression is a significant and independent prognostic marker for postoperative survival in breast cancer.
- The findings suggest P-glycoprotein expression may influence the biological behavior of breast cancers.
- Further research is warranted to explore therapeutic strategies targeting P-glycoprotein in breast cancer.